PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.30%
Net income growth 1.25-1.5x ORCL's 8.49%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
4.39%
D&A growth well above ORCL's 4.28%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-54.55%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
7.55%
SBC growth well above ORCL's 14.02%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-566.42%
Both reduce yoy usage, with ORCL at -193.15%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-145.32%
Both yoy AR lines negative, with ORCL at -82.73%. Martin Whitman would suspect an overall sector lean approach or softer demand.
197.52%
Inventory shrinking or stable vs. ORCL's 464.56%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-89.52%
Negative yoy AP while ORCL is 115.65%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
45.91%
Some yoy usage while ORCL is negative at -280.29%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-176.56%
Negative yoy while ORCL is 35.90%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-35.27%
Both yoy CFO lines are negative, with ORCL at -76.68%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
14.94%
Some CapEx rise while ORCL is negative at -30.28%. John Neff would see competitor possibly building capacity while we hold back expansions.
13.72%
Less M&A spending yoy vs. ORCL's 30.28%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-3.51%
Negative yoy purchasing while ORCL stands at 54.11%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
6.03%
Below 50% of ORCL's 538.79%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
115.70%
We have some outflow growth while ORCL is negative at -30.28%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
68.93%
Lower net investing outflow yoy vs. ORCL's 139.90%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-44.59%
Both yoy lines negative, with ORCL at -63.84%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
3.08%
Buyback growth below 50% of ORCL's 25.15%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.